DE69313291D1 - Phosphonoessigsäure und ester als antientzündungsmittel - Google Patents

Phosphonoessigsäure und ester als antientzündungsmittel

Info

Publication number
DE69313291D1
DE69313291D1 DE69313291T DE69313291T DE69313291D1 DE 69313291 D1 DE69313291 D1 DE 69313291D1 DE 69313291 T DE69313291 T DE 69313291T DE 69313291 T DE69313291 T DE 69313291T DE 69313291 D1 DE69313291 D1 DE 69313291D1
Authority
DE
Germany
Prior art keywords
image
ignitant
ester
phosphonoacetic acid
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69313291T
Other languages
English (en)
Inventor
Richard Nugent
David Anderson
Stephen Schlachter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Pharmacia and Upjohn Co
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn Co, Upjohn Co filed Critical Pharmacia and Upjohn Co
Application granted granted Critical
Publication of DE69313291D1 publication Critical patent/DE69313291D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4056—Esters of arylalkanephosphonic acids
    • C07F9/4059—Compounds containing the structure (RY)2P(=X)-(CH2)n-C(=O)-(CH2)m-Ar, (X, Y = O, S, Se; n>=1, m>=0)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F17/00—Metallocenes
    • C07F17/02—Metallocenes of metals of Groups 8, 9 or 10 of the Periodic Table
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4018—Esters of cycloaliphatic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/58—Pyridine rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6503—Five-membered rings
    • C07F9/65031—Five-membered rings having the nitrogen atoms in the positions 1 and 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C07F9/6512—Six-membered rings having the nitrogen atoms in positions 1 and 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69313291T 1992-08-07 1993-06-09 Phosphonoessigsäure und ester als antientzündungsmittel Expired - Lifetime DE69313291D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92687992A 1992-08-07 1992-08-07
PCT/US1993/005365 WO1994003463A1 (en) 1992-08-07 1993-06-09 Phosphonoacetic esters and acids as anti-inflammatories

Publications (1)

Publication Number Publication Date
DE69313291D1 true DE69313291D1 (de) 1997-09-25

Family

ID=25453835

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69313291T Expired - Lifetime DE69313291D1 (de) 1992-08-07 1993-06-09 Phosphonoessigsäure und ester als antientzündungsmittel

Country Status (13)

Country Link
US (2) US5565441A (de)
EP (1) EP0654035B1 (de)
JP (1) JPH07509712A (de)
CN (1) CN1086218A (de)
AT (1) ATE157097T1 (de)
AU (1) AU4407493A (de)
DE (1) DE69313291D1 (de)
IL (1) IL106435A0 (de)
MX (1) MX9304780A (de)
PH (1) PH30956A (de)
TW (1) TW226021B (de)
WO (1) WO1994003463A1 (de)
ZA (1) ZA935380B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004066469A2 (en) * 2003-01-22 2004-08-05 Valence Technology, Inc. Electrolyte for use in phosphate based lithium ion/polymer cells

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3683080A (en) * 1970-08-28 1972-08-08 Procter & Gamble Compositions for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue
DE2310450A1 (de) * 1973-03-02 1974-09-05 Henkel & Cie Gmbh Komplexbildner fuer mehrwertige metallionen
DE2360797C2 (de) * 1973-12-06 1985-05-23 Henkel KGaA, 4000 Düsseldorf Pharmazeutische Präparate
FR2531088B1 (fr) * 1982-07-29 1987-08-28 Sanofi Sa Produits anti-inflammatoires derives de l'acide methylenediphosphonique et leur procede de preparation
PH27078A (en) * 1984-12-21 1993-02-01 Procter & Gamble Pharmaceutical compositions containing geminal diphosphonates
US5071840A (en) * 1986-12-19 1991-12-10 Norwich Eaton Pharmaceuticals, Inc. Certain heterocyclic substituted diphosphonate compounds pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism
IL84731A0 (en) * 1986-12-19 1988-05-31 Norwich Eaton Pharma Heterocycle-substituted diphosphonic acids and salts and esters and pharmaceutical compositions containing them
IT1242565B (it) * 1990-09-14 1994-05-16 Marposs Spa Apparecchiatura per il controllo di una pluralita' di pezzi meccanici e relativo metodo di controllo.
EP0521622B1 (de) * 1991-07-03 1997-08-13 PHARMACIA & UPJOHN COMPANY Pyrazolopyrimiden- und Pyrimidinylbisphosphonsäureester als entzündungshemmende Mittel
US5312814A (en) * 1992-12-09 1994-05-17 Bristol-Myers Squibb Co. α-phosphonocarboxylate squalene synthetase inhibitors

Also Published As

Publication number Publication date
EP0654035A1 (de) 1995-05-24
CN1086218A (zh) 1994-05-04
PH30956A (en) 1997-12-23
EP0654035B1 (de) 1997-08-20
US5565441A (en) 1996-10-15
TW226021B (de) 1994-07-01
JPH07509712A (ja) 1995-10-26
ATE157097T1 (de) 1997-09-15
ZA935380B (en) 1995-01-26
IL106435A0 (en) 1993-11-15
AU4407493A (en) 1994-03-03
MX9304780A (es) 1994-02-28
US5643895A (en) 1997-07-01
WO1994003463A1 (en) 1994-02-17

Similar Documents

Publication Publication Date Title
AU586248B2 (en) (Meth)-acrylic acid esters and their use
DE3762412D1 (de) (meth)acrylsaeureester und ihre verwendung zur herstellung von dentalmassen.
GB2306958B (en) Oximesulfonic acid esters and the use thereof as latent sulfonic acids
EP0604641A4 (de) Zusammensetzung, die aminderivate oder aminverwandte derivate der benzoesäure enthält, und ihre verwendung einschliesslich der behandlung von entzündlichen erkrankungen.
FI972865A (fi) Hydroksimetyyli-imidatsodiatseptiinejä ja niiden esterit
ATE152728T1 (de) Pyrazolopyrimidin- und pyrimidinylbisphosphonsäureester als entzündungshemmende mittel
FR2354091A1 (fr) Utilisation d'esters aliphatiques d'acide 2-methyl-2-alkylalcanoiques comme matieres aromatiques et compositions de parfums en contenant
FI802559A (fi) Foerfarande och anordning foer utfodring av djur i synnerhet grisar och svin
BR9611472A (pt) Compostos de di-terc-butilfenol contendo enxofre úteis como agentes antiinflamatórios
ATE151067T1 (de) Vpa-analoge antiepileptika
DE69313291D1 (de) Phosphonoessigsäure und ester als antientzündungsmittel
FR2355822A1 (fr) Derives d'esters de l'acide indolacetique. utiles comme anti-inflammatoires et analgesiques
BE875142A (fr) Compositions anaerobies stabilisees contenant des acides
BR9707342A (pt) Dihidrobensofurano e compostos correlatod úteis como agentes antiinflamatórios
ATE181388T1 (de) Modulare, nutzungsflexible hausanordnung
ES8403922A1 (es) "procedimiento para preparar nuevos esteres de acido tiolfosforico"
DE69203142D1 (de) Von l-Glutaminsäure abgeleitete Süssungsmittel, Verfahren zu ihrer Herstellung.
DE59403903D1 (de) Verfahren zur Herstellung von gegebenfalls 2-substituierten 5-Chlorimidazolen
FI934252A (fi) 1,5,6,7-tetrahydro-4H-indazol-4-oner innehaollande laekemedel, nya 1,5,6,7-tetrahydro-4H-indazol-4-oner och foerfarande foer deras framstaellning
JPS56142260A (en) 2-azetidinone and its preparation
CA2073673A1 (en) Esters of 2-arylmethyl-1-naphthol derivatives as 5-lipoxygenase inhibitors

Legal Events

Date Code Title Description
8332 No legal effect for de